Research Roundup

Debbie Rigby 18/11/2025

Debbie Rigby rounds up the latest in research news SGLT2 Inhibitors and External Genital Infection in Male Patients with Type 2 Diabetes In this large cohort study patients with T2D newly receiving SGLT2Is were at a higher risk (HR 1.65) of male external genital infection including balanoposthitis, scrotal infections and epididymoorchitis compared with those receiving

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Research Roundup

Previous Docs slam campaign promoting pharmacist prescribing

Next Training underway for SDPR rollout

MENU

ajp.com.au

Previous Docs slam campaign promoting pharmacist prescribing

Next Training underway for SDPR rollout

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.